Neonatal Neurological Examination to Detect Infants at Risk

Diagnostic Value of the Neonatal Neurological Examination to Detect Infants at Risk for Neurological Abnormalities

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05772416

Enrollment

100

Registered

2023-03-16

Start date

2021-09-01

Completion date

2025-08-31

Last updated

2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Encephalopathy

Brief summary

The study aims to establish the diagnostic vcalue of a structured neurological examination to detect eraly neurological abnormlaities in infants at risk of neurological abnormlaiyies.

Detailed description

The study aims to establish the diagnostic vcalue of a structured neurological examination to detect eraly neurological abnormlaities in infants at risk of neurological abnormlaiyies. Infants at risk of neurological abnormlaiyies, such as very pèretrm infants and infants with asphyxia or with overt neyurologocal abnormla signs suh as convilsions will be assessed with a structured neurological examination and followed over time.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Hours to 1 Weeks

Inclusion criteria

all newborns with neonatal encephaolopathy or at risk for neurological abnormlaities, such as preterm infants born below 34 weeks or those with convusions

Exclusion criteria

families unwilling to sign consent

Design outcomes

Primary

Measure	Time frame	Description
Hammersmith Neonatal and infant Neurological examination	5 years	neurological examination witha score from 0 to 75 with 75 indicating best performance

Countries

Italy

Contacts

Primary ContactEugenio Mercuri, MD

eugeniomaria.mercuri@policlinicogemelli.it+39 063015

Backup ContactMarika Pane, MD

marika.pane@policlinicogemelli.it063015

Outcome results